Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Feb 27.
Published in final edited form as: Theor Chem Acc. 2015 Dec 28;135(1):15. doi: 10.1007/s00214-015-1788-2

Reaction Pathway for Cocaine Hydrolase-Catalyzed Hydrolysis of (+)-Cocaine

Yuan Yao a,b, Junjun Liu a,c, Fang Zheng a, Chang-Guo Zhan a,*
PMCID: PMC5328586  NIHMSID: NIHMS851228  PMID: 28250715

Abstract

A recently designed and discovered cocaine hydrolase (CocH), engineered from human butyrylcholinesterase (BChE), has been proven promising as a novel enzyme therapy for treatment of cocaine overdose and addiction because it is highly efficient in catalyzing hydrolysis of naturally occurring (−)-cocaine. It has been known that the CocH also has a high catalytic efficiency against (+)-cocaine, a synthetic enantiomer of cocaine. Reaction pathway and the corresponding free energy profile for the CocH-catalyzed hydrolysis of (+)-cocaine have been determined, in the present study, by performing first-principles pseudobond quantum mechanical/molecular mechanical (QM/MM)-free energy (FE) calculations. Acordingt to the QM/MM-FE results, the catalytic hydrolysis process is initiated by the nucleophilic attack on carbonyl carbon of (−)-cocaine benzoyl ester via hydroxyl oxygen of S198 side chain, and the second reaction step (i.e. dissociation of benzoyl ester) is rate-determining. This finding for CocH-catalyzed hydrolysis of (+)-cocaine is remarkably different from that for the (+)-cocaine hydrolysis catalyzed by bacterial cocaine esterase in which the first reaction step of the deacylation is associated with the highest free energy barrier (~17.9 kcal/mol). The overall free energy barrier (~16.0 kcal/mol) calculated for the acylation stage of CocH-catalyzed hydrolysis of (+)-cocaine is in good agreement with the experimental free energy barrier of ~14.5 kcal/mol derivated from the experimental kinetic data.

Introduction

Cocaine addiction and overdose have been a major public health problem affecting over 40 million Americans since 1980.1 Patients with cocaine addiction and overdose suffer heart attacks or strokes which are life-threatening. The disastrous medical and social consequences of cocaine addiction, such as violent crimes, loss in individual productivity, illness, and death, have made the development of an effective pharmacological treatment a high priority.2, 3 It is highly desired for development of an anti-cocaine medication to design an efficient cocaine-metabolizing enzyme which can be used an exogenous enzyme to rapidly detoxify cocaine and convert cocaine to biologically inactive metabolites.4

Butyrylcholinesterase (BChE) is the principal cocaine-metabolizing enzyme which hydrolyzes cocaine to biologically inactive metabolites in human plasma5 and, thus, cocaine hydrolysis catalyzed by BChE is the cocaine-metabolizing pathway most suitable for amplification in therapeutic development for treatment cocaine abuse. However, the wild-type BChE has a rather low catalytic efficiency (kcat = 4.1 min−1, KM = 4.5 μM) against naturally occurring (−)-cocaine.6 Our computational studies712 on BChE-catalyzed hydrolysis of (−)-cocaine and subsequent structure-and-mechanism-based computational design have led to the discovery of various BChE mutants with a considerably improved catalytic efficiency against (−)-cocaine.1324 Among these BChE mutants and cocaine-metabolizing enzymes reported so far, the A199S/F227A/S287G/A328W/Y332G mutant of human BChE has been studied most extensively in animal models of cocaine overdose or addiction due to its extremely high catalytic efficiency (kcatKM = ~1.84 × 109 M min–1) and the high in vivo activity.25 For example, pretreatment with this cocaine hydrolase (CocH) using a dose of 0.01 mg per mouse (i.v.) fully protected mice from the acute toxicity of a lethal dose of cocaine (180 mg/kg, i.p.), which shows that the CocH is efficient for cocaine detoxification.25 This CocH has been recognized as a true CocH in literature.26 It has also been demonstrated by independent animal studies2730 that the gene transfer using a viral vector encoding this CocH can yield plasma CocH levels that effectively detoxify cocaine, block cocaine-induced physiological effects, and diminish long-term cocaine intake for lengthy periods without immune reactions or cholinergic dysfunction.

Further, it has been demonstrated that the CocH can also efficiently hydrolyze (+)-cocaine.31, 32 However, the reaction pathway for CocH-catalyzed hydrolysis of (+)-cocaine remains to be uncovered. In the present study, we have employed the first-principles pseudobond quantum mechanical/molecular mechanical-free energy (QM/MM-FE)3336 calculations, which has been demonstrated to be a powerful tool in simulating a variety of enzymes,25, 3757 to reveal the reaction pathway for CocH-catalyzed hydrolysis of (+)-cocaine.

Based on the detailed mechanistic insights obtained from our recent computational studies on carboxylic esters (e.g. acetylcholine, butyrylcholine, and (−)-cocaine) for their hydrolyses catalyzed by human BChE (or mutant) or bacterial cocaine esterase (CocE),10, 15, 25, 43, 5863 the ester hydrolysis always consists of two stages: acylation and deacylation as shown in Scheme 1. Scheme 1 indicates that CocH-catalyzed hydrolyses of (+)-cocaine and (−)-cocaine share the common deacylation stage. Since the detailed reaction pathway for CocH-catalyzed hydrolysis of (−)-cocaine has already been elucidated in our previous study60, the present study is focused on the acylation stage for CocH-catalyzed hydrolysis of (+)-cocaine. Based on the computational results, the second reaction step of the acylation is associated with the highest free energy barrier for CocH-catalyzed hydrolysis of (+)-cocaine, which is remarkably different from the (+)-cocaine hydrolysis catalyzed by CocE (bacterial cocaine esterase) in which the first reaction step of the deacylation is rate-determining. The overall free energy barrier calculated for the acylation stage of CocH-catalyzed hydrolysis of (+)-cocaine is in good agreement with the experimental kinetic data.

Scheme 1.

Scheme 1

The reaction mechanisms for CocH-catalyzed hydrolyses of (+)- and (−)-cocaine.

Computational Methods

Structure preparation

The initial structure of the Michaelis–Menten complex (ES) of CocH binding with (+)-cocaine was constructed on the basis of the QM/MM-optimized geometry of the corresponding complex of (−)-cocaine in our previous study.60 The system was solvated in an orthorhombic box of TIP3P water molecules64 with a minimum solute-wall distance of 10 Å. After full energy minimization, the prepared system was equilibrated via the gradual increase in temperature from 10 to 298.15 K during molecular dynamics (MD) simulation. Then, the production MD simulation was performed for ~2 ns at 298.15 K. The MD simulation was performed by using the SANDER module of AMBER965, 66 in the present study. During the MD simulation, the time step was set as 2 fs with a cutoff value of 10 Å for non-bonded interactions. The SHAKE algorithm67, 68 was used to constrain all covalent bonds involving hydrogen atoms, and the particle mesh Ewald (PME) method was employed to treat long-range electrostatic interactions.

QM/MM-FE Simulation

The general QM/MM-FE methodology has been described in detail in the literature.33, 35, 36, 43 Here we only briefly discuss the part most relevant to the present work. The initial structure for QM/MM calculations was prepared from the snapshot close to the average structure of the MD trajectory. The pseudobond QM/MM method33, 35 implemented recently in a revised version25 of Gaussian0369 and AMBER870 programs was used for all of the QM/MM calculations. The pseudobond approach was used to treat the QM-MM interface, where each boundary atom of MM part is replaced by a seven-valence electron atom with an effective core potential, forming a pseudobond with the boundary atom of QM part. In QM/MM calculation, all atoms of (+)-cocaine and the side chains of S198, H438, and E325 residues were considered as the QM atoms, whereas other atoms were treated as MM atoms (Figure 1). The QM/MM calculations were carried out using an iterative minimization procedure36 at the B3LYP/6-31G*:AMBER level, i.e. the QM calculations at the B3LYP/6-31G* level and the MM calculations using the AMBER force field implemented in the AMBER8 program. For calculations on the QM subsystem, the geometry optimization convergence criterion followed the original Gaussian03 default criteria; for calculations on the MM subsystem, the convergence criterion for geometry optimization was that the root-mean-square deviation (RMSD) value of the energy gradient < 0.1 kcal·mol−1·Å−1. The minimum-energy path was then determined by using an iterative restrained optimization procedure, which was repeatedly applied to the different points along the reaction coordinate. Full QM/MM geometry-optimizations and vibrational frequency analyses at the B3LYP/6-31G*:AMBER level were performed to characterize the reactant, intermediates, and transition states. The contribution of the QM subsystem fluctuation to the free energy change was then evaluated with the obtained vibrational frequencies using the harmonic approximation. In addition, single-point energy calculations were performed at the QM/MM(MP2/6-31+G*:AMBER) level for each geometry along the minimum-energy path.

Figure 1.

Figure 1

Division of the QM/MM system for simulating CocH-catalyzed (+)-cocaine hydrolysis (upper) and plots of RMSD and key internuclear distances (D1 to D5) vs the simulation time in the MD simulation on the enzyme-substrate complex (middle and bottom). Atoms in blue are treated by QM method. Three boundary carbon atoms in red are treated with the improved pseudobond parameters.33 All other atoms belong to the MM subsystem.

The free energy changes associated with the QM-MM interaction were then more reasonably determined by the free energy perturbation (FEP) method36, 71 implemented in a revised version43 of the AMBER8 program. In the FEP calculations, the time step was 2 fs, and bond lengths involving hydrogen atoms were constrained. The QM subsystem was frozen at different points along the reaction path in sampling of the MM subsystem at 298.15 K.36 Each FEP calculation consisted of 50 ps of equilibration and 300 ps of sampling, which is a reliable protocol validated in the previous computational studies.12, 72, 73

The MD simulation and QM/MM-FE calculations were performed on a supercomputer (e.g. IBM X-series Cluster with 340 nodes or 1,360 processors) at University of Kentucky Center for Computational Sciences. The other less-time-consuming modeling and computations were carried out on SGI Fuel workstations and a 34-processor IBM x335 Linux cluster in our own lab.

Results and Discussion

BChE-(+)-Cocaine Binding Structure

A ~2 ns MD simulation was performed on the ES complex. The MD-simulated RMSD values for the Cα atoms (depicted in Figure 1) versus the simulation time were very stable, showing that the simulated structure of ES complex was in a stable equilibrium state. The trace D1 is the internuclear distance between the hydroxyl oxygen (Oγ) of S198 residue and the carbonyl carbon (Cζ) of (+)-cocaine benzoyl ester. The trace D2 is the internuclear distance between the hydroxyl hydrogen (Hγ) of S198 residue and the nitrogen (Nε) of H438 residue. The traces D3, D4, and D5 represent the internuclear distances between the carbonyl oxygen (Oη) of (+)-cocaine benzoyl ester and the NH hydrogen atom of G117, NH hydrogen atom of S199, and hydroxyl hydrogen of S199, respectively. In the MD simulation, the average value of D1 was ~3.45±0.13 Å, showing that (+)-cocaine was located at an appropriate position for the nucleophilic attack on the carbonyl carbon (Cζ) of (+)-cocaine by the hydroxyl oxygen Oγ of S198 residue. The average value of D2 was ~1.87±0.10 Å, indicating that H438 residue of the BChE catalytic triad was well positioned to facilitate the nucleophilic attack by accepting a proton from S198 residue. The average values of D3, D4, and D5 were 2.61±0.15 Å, 2.40±0.18 Å, 1.89±0.14 Å, respectively, and did not significantly change over the trajectory, indicating that the carbonyl oxygen Oη of (+)-cocaine forms stable hydrogen bonds with the oxyanion hole.

Fundamental Reaction Pathway

According to our pseudobond QM/MM reaction-coordinate calculations at the B3LYP/6-31G*:AMBER level, the acylation stage of CocH-catalyzed hydrolysis of (+)-cocaine consists of two reaction steps. The first step is the nucleophilic attack on the carbonyl carbon (Cζ) of (+)-cocaine benzoyl ester by the Oγ atom of catalytic S198, and the second step is the dissociation between the benzoyl ester and ecgonine methyl ester of (+)-cocaine.

Step 1: Nucleophilic attack on the benzoyl carbonyl carbon (Cζ) by the hydroxyl oxygen (Oγ) of S198

In the nucleophilic attack process, the Oγ atom of S198 side chain attacks the carbonyl carbon (Cζ) of (+)-cocaine benzoyl ester, while the Hγ proton on the S198 side chain transfers to the nitrogen (Nε) atom on the H438 side chain. Since the break of Oγ–Hγ bond and the formations of both Cζ–Oγ and Nε–Hγ bonds are involved in this reaction step, the nature of this chemical reaction step can be reflected by the distances between Oγ and Hγ atoms (ROγ–Hγ), between Cζ and Oγ atoms (RCζ–Oγ), and between Nε and Hγ atoms (RNε–Hγ). Therefore, ROγ–Hγ – RCζ–Oγ – RNε–Hγ was set as the reaction coordinate for the QM/MM reaction-coordinate calculations for this reaction step. The reactant, intermediate, and transition state were characterized by full geometry optimizations at the B3LYP/6-31G*:AMBER level followed by the harmonic vibrational frequency analysis. Their geometries are shown in Figure 2, and important geometric parameters are summarized in Table 1. During the reaction process of the nucleophilic attack, in which the carbonyl Cζ atom of (+)-cocaine benzoyl ester is attacked by the hydroxyl Oγ atom of S198, RCζ–Oγ is shortened from 2.64 Å in the reactant (ES) to 1.54 Å in the intermediate (INT1), indicating that a covalent bond between the Cζ and Oγ atoms is formed. The Cζ atom, which is sp2-hybridized and in a planar geometry with its three attached groups in ES, gradually changes into a tetrahedral geometry with the center on the sp3-hybridized Cζ atom in INT1 through the transition state (TS1). RNε–Hγ is shortened from 1.67 Å in ES to 1.03 Å in INT1 and ROγ–Hγ is elongated from 1.02 Å in ES to 1.98 Å in INT1, illustrating that the proton Hγ has been transferred to the Nε atom of H438 from the hydroxyl group of S198. In addition, the distance between the Hδ atom of H438 and the Oδ atom of E325 is shortened from 1.62 Å in ES to 1.42 Å in INT1, implying that the hydrogen bond (Nδ–Hδ…Oδ) involving the Hδ and Oδ atoms is stronger in INT1 than that in ES and, thus, plays an important role in stabilizing the developed positive charge on the protonated H438 in INT1.

Figure 2.

Figure 2

Key states for the first reaction step, the nucleophilic attack by Oγ atom of S198 side chain. The geometries were optimized at QM/MM(B3LYP/6-31G*:AMBER) level. The key distances in the figure are in Å. Carbon, oxygen, nitrogen, and hydrogen atoms are colored in green, red, blue, and white, respectively. The backbone of the protein is rendered as cartoon and colored in orange. The QM atoms are represented as ball and stick, and the surrounding residues rendered as sticks.

Table 1.

Important internuclear distances (Å) in the optimized geometries of the key states involved in the reaction process

Cζ–Oγ Oγ–Hγ Cζ–Oζ Oζ–Hγ Hγ–Nε Nδ–Hδ Hδ–Oδ Oη–Hη Oη–Hκ Oη–Hλ
ES 2.64 1.02 1.35 3.49 1.67 1.06 1.62 2.10 1.79 2.35
TS1 2.15 1.46 1.39 3.18 1.13 1.09 1.49 2.08 1.76 2.24
INT1 1.54 1.98 1.52 3.33 1.03 1.12 1.42 2.15 1.67 2.09
TS2 1.41 2.29 1.95 3.74 1.02 1.08 1.55 2.11 1.67 1.98
INT1′ 1.34 1.98 2.86 3.46 1.02 1.09 1.51 2.07 1.60 1.91
TS2′ 1.34 2.28 2.83 1.60 1.08 1.07 1.62 2.19 1.58 1.89
INT2 1.33 2.95 3.02 0.98 2.25 1.05 1.66 2.18 1.59 1.92

Step 2: Dissociation of (+)-Cocaine Benzoyl Ester

In this reaction step, the ecgonine group of (+)-cocaine gradually departs from the (+)-cocaine benzoyl ester group through the break of the benzoyl ester bond Cζ–Oζ while the proton (Hγ) of the protonated H438 residue gradually transfers to the benzoyl ester oxygen atom (Oζ) of (+)-cocaine. The changes of the distances of RCζ–Oζ, ROζ–Hγ and RNε–Hγ reflect the nature of this dissociation process of (+)-cocaine benzoyl ester. Thus the reaction coordinate for the current reaction step was chosen as RCζ–Oζ + RNε–Hγ – ROζ–Hγ. The intermediates and transition states were characterized through full geometry optimizations at QM/MM(B3LYP/6-31G*:AMBER) level followed by the harmonic vibrational frequency analysis. Their geometries are shown in Figure 3, and important geometric parameters are summarized in Table 1. Two transition states were observed on the minimum-energy path of the potential energy surface for the current reaction step. This observation is the same as that in the CocH-catalyzed hydrolysis of (−)-cocaine. These two transition states and the intermediate between the two transition states are labeled as TS2, TS2′, and INT1′, respectively. In INT1, a strong hydrogen bond Nε–Hγ…Oγ is formed between S198 terminal oxygen and H438 side chain (ROγ–Hγ is 1.98 Å). Although the Hγ atom is about to be transferred to the Oζ atom, the interaction between Hγ and Oζ atoms in INT1 is very weak (ROζ–Hγ is 3.33 Å), indicating an unfavorable environment for proton (Hγ) transfer from Nε atom of H438 to the leaving ester oxygen (Oζ) atom. In changing from INT1 to INT1′, the only remarkable structural difference is RCζ–Oζ, which is elongated to be 2.86 Å in INT1′ from 1.52 Å in INT1. The structural changes clearly show the break of the covalent bond Cζ–Oζ and the leave of the ecgonine group of (+)-cocaine. The Cζ atom, which is sp3-hybridized with a tetrahedral geometry in INT1, gradually changes into a planar geometry centering on the sp2-hybridized Cζ atom in INT1′ through the transition state (TS2). In INT1′, H438 keeps protonated as in INT1. From INT1′ to INT2, ROζ–Hγ is shortened to be 0.98 Å from 3.46 Å and RNε–Hγ is elongated to be 2.25 Å from 1.02 Å. Based on these two major differences between INT1′ and INT2, the proton (Hγ) transfers from the Nε atom of the protonated H438 to the leaving ester oxygen (Oζ) atom, and the protonated H438 in INT1′ changes back to the neutral state in INT2. The distance between the Hδ of H438 and the Oδ atom of E325 gradually changes from 1.42 Å in INT1 to 1.51 Å in INT1′ and then to 1.66 Å in INT2, indicating that the hydrogen bond (Nδ–Hδ…Oδ) between the Hδ and Oδ atoms becomes weaker and the gradual increase of the distance is consistent with the gradual change in the protonation state of H438.

Figure 3.

Figure 3

Key states except INT1 for the second reaction step, the dissociation of (+)-cocaine benzoyl ester. The geometries were optimized at QM/MM(B3LYP/6-31G*:AMBER) level. The structure of INT1 is given in Figure 2C. This figure is represented using the same scheme as that for Figure 2.

Energetics

In order to accurately calculate the energetics, we carried out further QM/MM single-point energy calculations at the QM/MM(MP2/6-31+G*:AMBER) level by using geometries optimized at the QM/MM(B3LYP/6-31G*:AMBER) level. For each geometry along the minimum-energy path, the ESP charges on QM atoms were determined from the QM/MM single-point energy calculation, and used in subsequent FEP simulations for estimating the free energy changes along the reaction path. Depicted in Figure 4 is the energy profile determined by the QM/MM-FE calculations excluding the zero-point and thermal corrections for the QM subsystem. The values in parentheses are the corresponding relative free energies with the zero-point and thermal corrections for the QM subsystem. The free energy barrier for the first reaction step is ~0.8 kcal/mol. For the second reaction step, i.e. the dissociation of cocaine benzyl ester, two transition states (TS2 and TS2′) were found on the minimum-energy path. The free energy barrier for the two reaction processes associated with TS2 and TS2′ are ~11.1 and ~5.8 kcal/mol, respectively. Since the energy of TS2′ is ~4.9 kcal/mol higher than that of TS2, the overall free energy barrier for the second reaction step is ~16.0 kcal/mol, which is the free energy change from INT1 to TS2′. It is significantly higher than that of the first reaction step (~0.8 kcal/mol). Therefore, the second reaction step, i.e. the dissociation of cocaine benzyl ester, is rate-determining for the acylation stage.

Figure 4.

Figure 4

Free energy profile determined by the MP2/6-31+G*:AMBER QM/MM-FE calculations excluding the zero-point and thermal corrections for the QM subsystem. The values in parentheses are relative free energies including the zero-point and thermal corrections for the QM subsystem.

As mentioned above, CocH-catalyzed (+)- and (−)-cocaine hydrolyses share the common deacylation stage. The free energy barrier was calculated to be ~10.9 kcal/mol for the deacylation stage.60 Clearly, the second reaction step in the acylation stage with the free energy barrier of ~16.0 kcal/mol is the rate-determining step for the CocH-catalyzed hydrolysis of (+)-cocaine. Notably, the rate-determining step for CocH-catalyzed hydrolysis of (+)-cocaine is remarkably different from that for bacterial CocE-catalyzed hydrolysis of (+)-cocaine. For bacterial CocE-catalyzed hydrolysis of (+)-cocaine, the highest free energy barrier (17.9 kcal/mol) is associated with the first step of the deacylation stage according to the QM/MM-FE calculations at the same level.74 Compared to bacterial CocE-catalyzed hydrolysis of (+)-cocaine, the free energy barrier (~10.9 kcal/mol) calculated for the deacylation stage of CocH-catalyzed hydrolysis of (+)/(–)-cocaine is significantly lower (by ~7 kcal/mol), and the free energy barrier (~16.0 kcal/mol) calculated for the acylation stage of CocH-catalyzed hydrolysis of (+)-cocaine is significantly higher (by ~7 kcal/mol), as seen in Table 2. As a result, the overall free energy barrier of ~16.0 kcal/mol for CocH-catalyzed hydrolysis of (+)-cocaine is ~1.9 kcal/mol lower than that for bacterial CocE-catalyzed hydrolysis of (+)-cocaine.

Table 2.

Summary of the calculated free energy barriers (kcal/mol) for the acylation and deacylation stages of the enzymatic (+)-cocaine hydrolysis reactions in comparison with experimentally determined catalytic rat constants.

Enzyme Calculated free energy barriers kcat (min−1)b
Individual stage Overall
CocH Acylation 16.0 16.0 8990
Deacylation 10.9
Bacterial CocEa Acylation 9.1 17.9 1078
Deacylation 17.9
a

The data for bacterial CocE were reported in ref.74

b

The experimental catalytic rate constant determined in the room temperature for CocH-catalyzed hydrolysis of (+)-cocaine75 and bacterial CocE-catalyzed hydrolysis of (+)-cocaine.74

To validate the computational data, we carried out experimental kinetic analysis on the CocH-catalyzed hydrolysis of (+)-cocaine;75 in fact, the computational studies described in this report were actually completed far before the experimental study75, but the submission of this report for publication was delayed considerably due to some unexpected reason. The experimental kinetic analysis revealed that catalytic rate constant (kcat = 8990 min−1)75 for CocH-catalyzed hydrolysis of (+)-cocaine is indeed significantly larger than that for bacterial CocE-catalyzed hydrolysis of (+)-cocaine (kcat = ~1078 min−1)74 determined in the room temperature. Further, based on the experimentally determined kinetic data (kcat = 8990 min−1), the free energy barrier for CocH-catalyzed hydrolysis of (+)-cocaine should be ~14.5 kcal/mol according to the conventional transition state theory.76 The calculated free energy barrier of ~16.0 kcal/mol is reasonably close to the experimentally determined free energy barrier of ~14.5 kcal/mol.

Conclusion

In the present study, first-principles pseudobond quantum mechanical/molecular mechanical (QM/MM)-free energy (FE) calculations have been performed to elucidate the reaction mechanism for (+)-cocaine hydrolysis catalyzed by a highly efficient cocaine hydrolase (CocH, which is the A199S/F227A/S287G/A328W/Y332G mutant of human BChE). During the acylation stage, the hydroxyl oxygen (Oγ) of S198 side chain initiates the nucleophilic attack on carbonyl carbon (Cζ) of (+)-cocaine benzoyl ester, which leads to formation of a tetrahedral intermediate. The developing negative charge of carbonyl oxygen (Oη) in the tetrahedral intermediate is stabilized by oxyanion hole through strong hydrogen-bonding interactions. Meanwhile, a proton (Hγ) gradually transfers from the hydroxyl group of S198 side chain to the Nε atom of the H438 side chain. Then, the benzoyl ester bond Cζ–Oζ of (+)-cocaine is broken and the protonated H438 transfers the proton (Hγ) to the ester oxygen (Oζ) of the leaving ecgonine group, completing the acylation stage. The second reaction step of the acylation stage is identified as the rate-determining step of the CocH-catalyzed hydrolysis of (+)-cocaine. The uncovered reaction mechanism for CocH-catalyzed hydrolysis of (+)-cocaine is remarkably different from that for bacterial CocE-catalyzed hydrolysis of (+)-cocaine in which the first reaction step of the deacylation is rate-determining. The overall free energy barrier (~16.0 kcal/mol) calculated for CocH-catalyzed hydrolysis of (+)-cocaine is significantly lower than that (~17.9 kcal/mol) calculated for bacterial CocE-catalyzed hydrolysis of (+)-cocaine, which is consistent with the relative values of the experimental rate constant (kcat = 8990 min−1 for CocH-catalyzed hydrolysis of (+)-cocaine and kcat = ~1078 min−1 for bacterial CocE-catalyzed hydrolysis of (+)-cocaine) at the room temperature. In addition, the calculated free energy barrier of ~16.0 kcal/mol is close to the experimentally derived free energy barrier of ~14.5 kcal/mol, suggesting that the obtained computational insights into the catalytic mechanism are reasonable.

Acknowledgments

This work was supported in part by the NIH (grants R01 DA035552, R01 DA013930, R01 DA032910, and R01 DA025100), NSF (grant CHE-1111761), and NSFC (grant No.21102050). The entire research was performed at the University of Kentucky. The authors acknowledge the Center for Computational Sciences (CCS) at University of Kentucky for supercomputing time on IBM X-series Cluster with 340 nodes or 1,360 processors.

References

  • 1.Landry DW, Yang GXQ. J Addict Dis. 1997;16:1–17. doi: 10.1300/J069v16n03_01. [DOI] [PubMed] [Google Scholar]
  • 2.Gorelick DA. Drug Alcohol Depend. 1997;48:159. doi: 10.1016/s0376-8716(97)00119-1. [DOI] [PubMed] [Google Scholar]
  • 3.Zheng F, Zhan C-G. Future Med Chem. 2010;3:9–13. doi: 10.4155/fmc.10.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Zheng F, Zhan C-G. Future Med Chem. 2012;4:125–128. doi: 10.4155/fmc.11.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhan C-G, Zheng F, Landry DW. J Am Chem Soc. 2003;125:2462–2474. doi: 10.1021/ja020850+. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Sun H, Pang Y-P, Lockridge O, Brimijoin S. Mol Pharmacol. 2002;62:220–224. doi: 10.1124/mol.62.2.220. [DOI] [PubMed] [Google Scholar]
  • 7.Zhan C-G, Zheng F, Landry DW. J Am Chem Soc. 2003;125:2462–2474. doi: 10.1021/ja020850+. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hamza A, Cho H, Tai H-H, Zhan C-G. The Journal of Physical Chemistry B. 2005;109:4776–4782. doi: 10.1021/jp0447136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zhan C-G, Gao D. Biophysical Journal. 2005;89:3863–3872. doi: 10.1529/biophysj.105.070276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gao D, Zhan C-G. The Journal of Physical Chemistry B. 2005;109:23070–23076. doi: 10.1021/jp053736x. [DOI] [PubMed] [Google Scholar]
  • 11.Gao D, Zhan C-G. Proteins: Structure, Function, and Bioinformatics. 2006;62:99–110. doi: 10.1002/prot.20713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liu J, Zhan C-G. J Chem Theory Comput. 2012;8:1426–1435. doi: 10.1021/ct200810d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pan Y, Gao D, Yang W, Cho H, Yang G, Tai H-H, Zhan C-G. Proc Natl Acad Sci USA. 2005;102:16656–16661. doi: 10.1073/pnas.0507332102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gao D, Cho H, Yang W, Pan Y, Yang G, Tai HH, Zhan C-G. Angewandte Chemie International Edition. 2006;45:653–657. doi: 10.1002/anie.200503025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pan Y, Gao D, Yang W, Cho H, Zhan C-G. Journal of the American Chemical Society. 2007;129:13537–13543. doi: 10.1021/ja073724k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zheng F, Yang WC, Ko MC, Liu JJ, Cho H, Gao DQ, Tong M, Tai HH, Woods JH, Zhan C-G. J Am Chem Soc. 2008;130:12148–12155. doi: 10.1021/ja803646t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yang W, Pan Y, Zheng F, Cho H, Tai H-H, Zhan C-G. Biophysical Journal. 2009;96:1931–1938. doi: 10.1016/j.bpj.2008.11.051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yang W, Pan Y, Fang L, Gao D, Zheng F, Zhan C-G. J Phys Chem B. 2010;114:10889–10896. doi: 10.1021/jp104989b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zheng F, Yang W, Xue L, Hou S, Liu J, Zhan C-G. Biochemistry. 2010;49:9113–9119. doi: 10.1021/bi1011628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Xue L, Ko M-C, Tong M, Yang W, Hou S, Fang L, Liu J, Zheng F, Woods JH, Tai H-H, Zhan C-G. Mol Pharmacol. 2011;79:290–297. doi: 10.1124/mol.110.068494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Yang W, Xue L, Fang L, Chen X, Zhan C-G. Chem Biol Interact. 2010;187:148–152. doi: 10.1016/j.cbi.2010.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Xue L, Hou S, Tong M, Fang L, Chen X, Jin Z, Tai H-H, Zheng F, Zhan C-G. Biochem J. 2013;453:447–454. doi: 10.1042/BJ20130549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Zheng F, Xue L, Hou S, Liu J, Zhan M, Yang W, Zhan C-G. Nature Commun. 2014;5:3457. doi: 10.1388/ncomms4457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chen X, Huang X, Geng L, Xue L, Hou S, Zheng X, Brimijoin S, Zheng F, Zhan C-G. Biochem J. 2015;466:243–251. doi: 10.1042/BJ20141266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Zheng F, Yang W, Ko M-C, Liu J, Cho H, Gao D, Tong M, Tai H-H, Woods JH, Zhan C-G. J Am Chem Soc. 2008;130:12148–12155. doi: 10.1021/ja803646t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gao Y, Orson FM, Kinsey B, Kosten T, Brimijoin S. Chem Biol Interact. 2010;187:421–424. doi: 10.1016/j.cbi.2010.02.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Geng L, Gao Y, Chen X, Hou S, Zhan C-G, Radic Z, Parks R, Russell SJ, Pham L, Brimijoin S. PLoS One. 2013;8:e67446. doi: 10.1371/journal.pone.0067446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Murthy V, Gao Y, Geng L, LeBrasseur N, White T, Brimijoin S. J Mol Neurosci. 2014;53:409–416. doi: 10.1007/s12031-013-0130-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zlebnik NE, Brimijoin S, Gao Y, Saykao AT, Parks RJ, Carroll ME. Neuropsychopharmacology. 2014;39:1538–1546. doi: 10.1038/npp.2014.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Murthy V, Gao Y, Geng L, LeBrasseur NK, White TA, Parks RJ, Brimijoin S. Vaccine. 2014;32:4155–4162. doi: 10.1016/j.vaccine.2014.05.067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Xue L, Hou S, Yang W, Fang L, Zheng F, Zhan C-G. Chem Biol Interact. 2013;203:57–62. doi: 10.1016/j.cbi.2012.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hou S, Xue L, Yang W, Fang L, Zheng F, Zhan C-G. Org Biomol Chem. 2013;11:7477–7485. doi: 10.1039/c3ob41713a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhang YK. J Chem Phys. 2005:122. [Google Scholar]
  • 34.Zhang YK. Theor Chem Acc. 2006;116:43–50. [Google Scholar]
  • 35.Zhang YK, Lee TS, Yang WT. J Chem Phys. 1999;110:46–54. [Google Scholar]
  • 36.Zhang YK, Liu HY, Yang WT. J Chem Phys. 2000;112:3483–3492. [Google Scholar]
  • 37.Cheng Y, Zhang Y, McCammon JA. J Am Chem Soc. 2005;127:1553–1562. doi: 10.1021/ja0464084. [DOI] [PubMed] [Google Scholar]
  • 38.Cisneros GA, Liu H, Zhang Y, Yang W. J Am Chem Soc. 2003;125:10384–10393. doi: 10.1021/ja029672a. [DOI] [PubMed] [Google Scholar]
  • 39.Corminboeuf C, Hu P, Tuckerman ME, Zhang Y. J Am Chem Soc. 2006;128:4530–4531. doi: 10.1021/ja0600882. [DOI] [PubMed] [Google Scholar]
  • 40.Hu P, Wang S, Zhang Y. J Am Chem Soc. 2008;130:3806–3813. doi: 10.1021/ja075896n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Hu P, Zhang Y. J Am Chem Soc. 2006;128:1272–1278. doi: 10.1021/ja056153+. [DOI] [PubMed] [Google Scholar]
  • 42.Liu H, Zhang Y, Yang W. J Am Chem Soc. 2000;122:6560–6570. [Google Scholar]
  • 43.Liu J, Hamza A, Zhan C-G. J Am Chem Soc. 2009;131:11964–11975. doi: 10.1021/ja903990p. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Wang L, Yu X, Hu P, Broyde S, Zhang Y. J Am Chem Soc. 2007;129:4731–4737. doi: 10.1021/ja068821c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wang S, Hu P, Zhang Y. J Phys Chem B. 2007;111:3758–3764. doi: 10.1021/jp067147i. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Xiao C, Zhang Y. J Phys Chem B. 2007;111:6229–6235. doi: 10.1021/jp068657f. [DOI] [PubMed] [Google Scholar]
  • 47.Zhang Y, Kua J, McCammon JA. J Am Chem Soc. 2002;124:10572–10577. doi: 10.1021/ja020243m. [DOI] [PubMed] [Google Scholar]
  • 48.Zhang Y, Kua J, McCammon JA. J Phys Chem B. 2003;107:4459–4463. [Google Scholar]
  • 49.Zheng F, Zhan CG. Org Biomol Chem. 2008;6:836–843. doi: 10.1039/b716268e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Chen X, Fang L, Liu JJ, Zhan CG. Biochemistry. 2012;51:1297–1305. doi: 10.1021/bi201786s. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Chen X, Zhao XY, Xiong Y, Liu JJ, Zhan CG. J Phys Chem B. 2011;115:12208–12219. doi: 10.1021/jp205509w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Wei DH, Lei BL, Tang MS, Zhan CG. J Am Chem Soc. 2012;134:10436–10450. doi: 10.1021/ja3006463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Qiao Y, Han K, Zhan C-G. Biochemistry. 2013;52:6467–6479. doi: 10.1021/bi400709v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Wei D, Fang L, Tang M, Zhan C-G. J Phys Chem B. 2013;117:13418–13434. doi: 10.1021/jp405337v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wei D, Huang X, Liu J, Tang M, Zhan C-G. Biochemistry. 2013;52:5145–5154. doi: 10.1021/bi400629r. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Qiao Y, Han K, Zhan C-G. Org Biomol Chem. 2014;12:2214–2227. doi: 10.1039/c3ob42464b. Cover Article. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Wei D, Tang M, Zhan C-G. Org Biomol Chem. 2015;13:6857–6865. doi: 10.1039/c5ob00737b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Gao DQ, Zhan CG. Proteins. 2006;62:99–110. doi: 10.1002/prot.20713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Hamza A, Cho H, Tai H-H, Zhan C-G. J Phys Chem B. 2005;109:4776–4782. doi: 10.1021/jp0447136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Liu J, Zhan C-G. J Chem Theory Comput. 2012;8:1426–1435. doi: 10.1021/ct200810d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Liu J, Zhao X, Yang W, Zhan C-G. J Phys Chem B. 2011;115:5017–5025. doi: 10.1021/jp200975v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Pan Y, Gao D, Yang W, Cho H, Yang G, Tai H-H, Zhan C-G. Proc Natl Acad Sci USA. 2005;102:16656–16661. doi: 10.1073/pnas.0507332102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Zhan CG, Gao D. Biophys J. 2005;89:3863–3872. doi: 10.1529/biophysj.105.070276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. J Chem Phys. 1983;79:926–935. [Google Scholar]
  • 65.Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, Onufriev A, Simmerling C, Wang B, Woods RJ. J Comput Chem. 2005;26:1668–1688. doi: 10.1002/jcc.20290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Case DA, Darden TA, Cheatham TE, Simmerling CL, Wang J, Duke RE, Luo R, Merz KM, Pearlman DA, Crowley M, Walker RC, Zhang W, Wang B, Hayik S, Roitberg A, Seabra G, Wong KF, Paesani F, Wu X, Brozell S, Tsui V, Gohlke H, Yang L, Tan C, Mongan J, Hornak V, Cui G, Beroza P, Mathews DH, Schafmeister C, Ross WS, Kollman PA. AMBER 2009. University of California; San Francisco: 2006. [Google Scholar]
  • 67.Miyamoto S, Kollman PA. J Comput Chem. 1992;13:952–962. [Google Scholar]
  • 68.Ryckaert JP, Ciccotti G, Berendsen HJC. J Comput Phys. 1977;23:327–341. [Google Scholar]
  • 69.Frisch MJTGW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian 03, Revision C.02. Gaussian Inc; Wallingford CT: 2004. [Google Scholar]
  • 70.Case DA, Darden TA, Cheatham ITE, Simmerling CL, Wang J, Duke RE, Luo R, Merz KM, Wang B, Pearlman DA, Crowley M, Brozell S, Tsui V, Gohlke H, Mongan J, Hornak V, Cui G, Beroza P, Schafmeister C, Caldwell JW, Ross WS, Kollman PA. AMBER 2008. University of California; San Francisco: 2004. [Google Scholar]
  • 71.Zhang Y, Liu H, Yang W. In: Computational Methods for Macromolecular Modeling-Challenges and Applications. Schlick T, Gan HH, editors. Springer-Verlag; New York: 2002. pp. 332–354. [Google Scholar]
  • 72.Liu J, Zhang Y, Zhan C-G. J Phys Chem B. 2009;113:16226–16236. doi: 10.1021/jp9055335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Liu JJ, Hamza A, Zhan C-G. Journal of the American Chemical Society. 2009;131:11964–11975. doi: 10.1021/ja903990p. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Liu JJ, Zhao XY, Yang WC, Zhan C-G. J Phys Chem B. 2011;115:5017–5025. doi: 10.1021/jp200975v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Xue L, Hou S, Yang W, Fang L, Zheng F, Zhan C-G. Chem Biol Interact. 2013;203:57–62. doi: 10.1016/j.cbi.2012.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Truhlar DG, Garrett BC. Annu Rev Phys Chem. 1984;35:159–189. [Google Scholar]

RESOURCES